American Portfolios Advisors Ocular Therapeutix, Inc Transaction History

American Portfolios Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Mar 24, 2023	BUY	$2.46 - $4.52 $738 - $1,355	300 New	300 $1.32 Million
Q3 2018 Mar 24, 2023	BUY	$5.42 - $6.99 $1,626 - $2,097	300 New	300 $2.06 Million
Q1 2018 Mar 24, 2023	BUY	$4.66 - $7.08 $1,398 - $2,124	300 New	300 $1.95 Million
Q4 2017 Mar 24, 2023	BUY	$3.73 - $6.37 $1,119 - $1,911	300	300 $1.34 Million

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $676M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.